Related references
Note: Only part of the references are listed.Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis
Lea Landolt et al.
PHYSIOLOGICAL REPORTS (2017)
Membrane-type matrix metalloproteinases: Their functions and regulations
Yoshifumi Itoh
MATRIX BIOLOGY (2015)
MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer
N. Akanuma et al.
BRITISH JOURNAL OF CANCER (2014)
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Roosmarijn E. Vandenbroucke et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer
Yu-zhou Wang et al.
TUMOR BIOLOGY (2014)
Significance of semaphorin-3A and MMP-14 protein expression in non-small cell lung cancer
Haiying Zhou et al.
ONCOLOGY LETTERS (2014)
Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression
Sonia Pahwa et al.
CANCERS (2014)
Combined features based on MT1-MMP expression, CD11b+immunocytes density and LNR predict clinical outcomes of gastric cancer
Chun-Wei Peng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
PK assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine
Randall Dere et al.
BIOANALYSIS (2013)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Increased serum level of membrane type 1-matrix metalloproteinase (MT1-MMP/MMP-14) in patients with breast cancer
P. Laudanski et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2010)
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis
Bernard Tetu et al.
BREAST CANCER RESEARCH (2006)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Share Paper
